Functional characterization of ferret CCL20 and CCR6 and identification of chemotactic inhibitors

Cytokine

Volumn 61, Issue 3, 2013, Pages 924-932

  Qin, Shulin ^a   Klamar, Cynthia R ^a   Fallert Junecko, Beth A ^a   Craigo, Jodi ^b,c   Fuller, Deborah H ^d   Reinhart, Todd A ^a  

^a UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

^d UNIVERSITY OF WASHINGTON   (United States)

Author keywords

CCL20; CCR6; Chemokine; EGCG; Ferret

Indexed keywords

CHEMOKINE RECEPTOR CCR6; COMPLEMENTARY DNA; EPIGALLOCATECHIN GALLATE; HYBRID PROTEIN; IMMUNOGLOBULIN G2A; M3 PROTEIN; MACROPHAGE INFLAMMATORY PROTEIN 3ALPHA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CELL CLONE; CHEMOTAXIS; CONTROLLED STUDY; DNA SEQUENCE; FERRET; GAMMAHERPESVIRINAE; MIGRATION INHIBITION; MOLECULAR CLONING; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHYLOGENY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURFACE PLASMON RESONANCE; SYNTHESIS;

AMINO ACID SEQUENCE; ANIMALS; CATECHIN; CHEMOKINE CCL20; CHEMOTAXIS; CLONING, MOLECULAR; DNA, COMPLEMENTARY; DOGS; FERRETS; MICE; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; PHYLOGENY; PROTEIN BINDING; RECEPTORS, CCR6; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS, DNA; VIRAL PROTEINS;

HERPESVIRIDAE; MURINAE; MUSTELA;

EID: 84875381696     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2012.12.015     Document Type: Article

References (44)

1. Zlotnik A., Yoshie O., Nomiyama H. The chemokine and chemokine receptor superfamilies and their molecular evolution. Genome Biol 2006, 7:243.
2. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000, 18:217-242.
3. Yang D., Chen Q., Hoover D.M., Staley P., Tucker K.D., Lubkowski J., et al. Many chemokines including CCL20/MIP-3alpha display antimicrobial activity. J Leukoc Biol 2003, 74:448-455.
4. Lafferty M.K., Sun L., DeMasi L., Lu W., Garzino-Demo A. CCR6 ligands inhibit HIV by inducing APOBEC3G. Blood 2010, 115:1564-1571.
5. Kortesidis A., Zannettino A., Isenmann S., Shi S., Lapidot T., Gronthos S. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 2005, 105:3793-3801.
6. Qin S., Sui Y., Murphey-Corb M.A., Reinhart T.A. Association between decreased CXCL12 and CCL25 expression and increased apoptosis in lymphoid tissues of cynomolgus macaques during SIV infection. J Med Primatol 2008, 37(Suppl. 2):46-54.
7. Youn B.S., Yu K.Y., Oh J., Lee J., Lee T.H., Broxmeyer H.E. Role of the CC chemokine receptor 9/TECK interaction in apoptosis. Apoptosis 2002, 7:271-276.
8. Schutyser E., Struyf S., Van Damme J. The CC chemokine CCL20 and its receptor CCR6. Cytokine Growth Factor Rev 2003, 14:409-426.
9. Comerford I., Bunting M., Fenix K., Haylock-Jacobs S., Litchfield W., Harata-Lee Y., et al. An immune paradox: how can the same chemokine axis regulate both immune tolerance and activation?: CCR6/CCL20: a chemokine axis balancing immunological tolerance and inflammation in autoimmune disease. Bioessays 2010, 32:1067-1076.
10. Ito T., Carson W.F.T., Cavassani K.A., Connett J.M., Kunkel S.L. CCR6 as a mediator of immunity in the lung and gut. Exp Cell Res 2011, 317:613-619.
11. Yang D., Chertov O., Bykovskaia S.N., Chen Q., Buffo M.J., Shogan J., et al. Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6. Science 1999, 286:525-528.
12. Cameron C.M., Cameron M.J., Bermejo-Martin J.F., Ran L., Xu L., Turner P.V., et al. Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets. J Virol 2008, 82:11308-11317.
13. Fang Y., Rowe T., Leon A.J., Banner D., Danesh A., Xu L., et al. Molecular characterization of in vivo adjuvant activity in ferrets vaccinated against influenza virus. J Virol 2010, 84:8369-8388.
14. Imai H., Shinya K., Takano R., Kiso M., Muramoto Y., Sakabe S., et al. The HA and NS genes of human H5N1 influenza A virus contribute to high virulence in ferrets. PLoS Pathog 2010, 6:e1001106.
15. Kang Y.M., Song B.M., Lee J.S., Kim H.S., Seo S.H. Pandemic H1N1 influenza virus causes a stronger inflammatory response than seasonal H1N1 influenza virus in ferrets. Arch Virol 2011, 156:759-767.
16. Rowe T., Leon A.J., Crevar C.J., Carter D.M., Xu L., Ran L., et al. Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology 2010, 401:257-265.
17. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011, 28:2731-2739.
18. Qin S., Alcorn J.F., Craigo J.K., Tjoeng C., Tarwater P.M., Kolls J.K., et al. Epigallocatechin-3-gallate reduces airway inflammation in mice through binding to proinflammatory chemokines and inhibiting inflammatory cell recruitment. J Immunol 2011, 186:3693-3700.
19. Qin S., Sui Y., Soloff A.C., Junecko B.A., Kirschner D.E., Murphey-Corb M.A., et al. Chemokine and cytokine mediated loss of regulatory T cells in lymph nodes during pathogenic simian immunodeficiency virus infection. J Immunol 2008, 180:5530-5536.
20. Fox J.M., Najarro P., Smith G.L., Struyf S., Proost P., Pease J.E. Structure/function relationships of CCR8 agonists and antagonists. Amino-terminal extension of CCL1 by a single amino acid generates a partial agonist. J Biol Chem 2006, 281:36652-36661.
21. Jensen K.K., Chen S.C., Hipkin R.W., Wiekowski M.T., Schwarz M.A., Chou C.C., et al. Disruption of CCL21-induced chemotaxis in vitro and in vivo by M3, a chemokine-binding protein encoded by murine gammaherpesvirus 68. J Virol 2003, 77:624-630.
22. Martin A.P., Canasto-Chibuque C., Shang L., Rollins B.J., Lira S.A. The chemokine decoy receptor M3 blocks CC chemokine ligand 2 and CXC chemokine ligand 13 function in vivo. J Immunol 2006, 177:7296-7302.
23. Parry C.M., Simas J.P., Smith V.P., Stewart C.A., Minson A.C., Efstathiou S., et al. A broad spectrum secreted chemokine binding protein encoded by a herpesvirus. J Exp Med 2000, 191:573-578.
24. van Berkel V., Barrett J., Tiffany H.L., Fremont D.H., Murphy P.M., McFadden G., et al. Identification of a gammaherpesvirus selective chemokine binding protein that inhibits chemokine action. J Virol 2000, 74:6741-6747.
25. Camp J.V., Svensson T.L., McBrayer A., Jonsson C.B., Liljestrom P., Bruder C.E. De-novo transcriptome sequencing of a normalized cDNA pool from influenza infected ferrets. PLoS One 2012, 7:e37104.
26. Herfst S., Schrauwen E.J., Linster M., Chutinimitkul S., de Wit E., Munster V.J., et al. Airborne transmission of influenza A/H5N1 virus between ferrets. Science 2012, 336:1534-1541.
27. Williams I.R. CCR6 and CCL20: partners in intestinal immunity and lymphorganogenesis. Ann NY Acad Sci 2006, 1072:52-61.
28. Hoover D.M., Boulegue C., Yang D., Oppenheim J.J., Tucker K., Lu W., et al. The structure of human macrophage inflammatory protein-3alpha /CCL20. Linking antimicrobial and CC chemokine receptor-6-binding activities with human beta-defensins. J Biol Chem 2002, 277:37647-37654.
29. Ghosh M., Shen Z., Schaefer T.M., Fahey J.V., Gupta P., Wira C.R. CCL20/MIP3alpha is a novel anti-HIV-1 molecule of the human female reproductive tract. Am J Reprod Immunol 2009, 62:60-71.
30. Osterholzer J.J., Ames T., Polak T., Sonstein J., Moore B.B., Chensue S.W., et al. CCR2 and CCR6, but not endothelial selectins, mediate the accumulation of immature dendritic cells within the lungs of mice in response to particulate antigen. J Immunol 2005, 175:874-883.
31. Yang D., Howard O.M., Chen Q., Oppenheim J.J. Cutting edge: immature dendritic cells generated from monocytes in the presence of TGF-beta 1 express functional C-C chemokine receptor 6. J Immunol 1999, 163:1737-1741.
32. Guo J.H., Fan M.W., Sun J.H., Jia R. Fusion of antigen to chemokine CCL20 or CXCL13 strategy to enhance DNA vaccine potency. Int Immunopharmacol 2009, 9:925-930.
33. Tarradas J., Alvarez B., Fraile L., Rosell R., Munoz M., Galindo-Cardiel I., et al. Immunomodulatory effect of swine CCL20 chemokine in DNA vaccination against CSFV. Vet Immunol Immunopathol 2011, 142:243-251.
34. Cabrera C., Artacho R., Gimenez R. Beneficial effects of green tea - a review. J Am Coll Nutr 2006, 25:79-99.
35. Clement Y. Can green tea do that? A literature review of the clinical evidence. Prev Med 2009, 49:83-87.
36. Higdon J.V., Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003, 43:89-143.
37. Wolfram S. Effects of green tea and EGCG on cardiovascular and metabolic health. J Am Coll Nutr 2007, 26:373S-388S.
38. Abboud P.A., Hake P.W., Burroughs T.J., Odoms K., O'Connor M., Mangeshkar P., et al. Therapeutic effect of epigallocatechin-3-gallate in a mouse model of colitis. Eur J Pharmacol 2008, 579:411-417.
39. Ahmed S., Pakozdi A., Koch A.E. Regulation of interleukin-1beta-induced chemokine production and matrix metalloproteinase 2 activation by epigallocatechin-3-gallate in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2006, 54:2393-2401.
40. Ahn H.Y., Xu Y., Davidge S.T. Epigallocatechin-3-O-gallate inhibits TNFalpha-induced monocyte chemotactic protein-1 production from vascular endothelial cells. Life Sci 2008, 82:964-968.
41. Takano K., Nakaima K., Nitta M., Shibata F., Nakagawa H. Inhibitory effect of (-)-epigallocatechin 3-gallate, a polyphenol of green tea, on neutrophil chemotaxis in vitro and in vivo. J Agri Food Chem 2004, 52:4571-4576.
42. Lin S.K., Chang H.H., Chen Y.J., Wang C.C., Galson D.L., Hong C.Y., et al. Epigallocatechin-3-gallate diminishes CCL2 expression in human osteoblastic cells via up-regulation of phosphatidylinositol 3-Kinase/Akt/Raf-1 interaction: a potential therapeutic benefit for arthritis. Arthritis Rheum 2008, 58:3145-3156.
43. Shin H.Y., Kim S.H., Jeong H.J., Kim S.Y., Shin T.Y., Um J.Y., et al. Epigallocatechin-3-gallate inhibits secretion of TNF-α, IL-6 and IL-8 through the attenuation of ERK and NF-kappaB in HMC-1 cells. Int Arch Allergy Immunol 2007, 142:335-344.
44. Zhu J., Wang O., Ruan L., Hou X., Cui Y., Wang J.M., et al. The green tea polyphenol (-)-epigallocatechin-3-gallate inhibits leukocyte activation by bacterial formylpeptide through the receptor FPR. Int Immunopharmacol 2009, 9:1126-1130.